News related to Naproxen and/or conditions it is approved for
NicOx' Naproxcinod Shows Highly Significant Reduction In Daytime Blood Pressure Versus Naproxen
Source: Hypertension News From Medical News Today [2008.11.13]
NicOx S.A. (Euronext Paris: COX) announced that a new analysis of the data from the 104 Ambulatory Blood Pressure Monitoring (ABPM) study for naproxcinod was presented yesterday at the American Heart Association Scientific Sessions 2008, in New Orleans, USA. This ABPM pilot study in hypertensive volunteers was designed to compare the 24-hour blood pressure profiles of naproxcinod 750 mg bid and naproxen 500 mg bid.
Celebrex, Naproxen Won't Prevent Mental Decline
Source: MedicineNet celecoxib Specialty [2008.05.13]
Title: Celebrex, Naproxen Won't Prevent Mental Decline
Category: Health News
Created: 5/13/2008 2:00:00 AM
Last Editorial Review: 5/13/2008
|
